Canine atopic dermatitis

Advice for veterinary professionals

Please select your country
Search this site
Novartis Animal Health

Home > Atopica > Mode of action


Mode of action

Atopica contains the immunomodulator cyclosporine A.

Targeted therapy

  • Atopica specifically targets the immune cells involved in the allergic response
  • Atopica targets T lymphocytes and other cells including langerhans cells, eosinophils and mast cells
  • It blocks the release of inflammatory molecules such as cytokines and histamines
  • Cyclosporine concentrates in the skin (ref Steffan J et al. Vet Dermatol; 2003; 14:11-22)
Do you want to receive regular updates?
Terms of use | Privacy policy | Contact us | Sitemap | © 2012 Novartis Animal Health Inc., Basel | 2010000 - 67